Mobile Monitoring Device for Respiratory Disorders

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen BySharon Chinthrajah, MD

Age: Any Age

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Stanford University

No Placebo Group

Trial Summary

What is the purpose of this trial?Recently, interest in ways to monitor and care for patients remotely has significantly increased due to concerns for infection control as well as a way to increase access to regular clinic visits that may be limited for socioeconomic and geographic reasons. However, remote care can be limited by a lack of objective data to help guide clinical care. With respect to respiratory disease, caring for patients remotely may be enhanced by the ability of patients to monitor at home such things as vital signs, lung sounds, and lung function by spirometry. Enhanced methods to follow symptoms and track medication compliance may also be beneficial. These enhancements could improve care and quality of life both for persons with acute respiratory illnesses and those with chronic respiratory disease (such as asthma or COPD). The purpose of this study is to develop and study methods for patients to monitor their respiratory health at home and make that data available to medical providers to improve their care.

Eligibility Criteria

This trial is for individuals aged 1 month or older with chronic respiratory diseases like asthma or COPD, acute respiratory illnesses, or even healthy volunteers. Participants must be able to give consent themselves or through a parent if underage and speak English. Those with significant cognitive impairment cannot join.

Inclusion Criteria

I am over 1 month old and have a chronic respiratory condition, an acute respiratory illness, or am healthy.

Exclusion Criteria

I have significant memory or thinking problems.

I do not speak English.

Participant Groups

The study is testing the use of mobile monitoring devices that allow patients to track their respiratory health at home. This data will then be used by medical providers to potentially improve patient care and overall quality of life.

1Treatment groups

Experimental Treatment

Group I: Mobile MonitoringExperimental Treatment1 Intervention

Participants will be asked to use a smartphone or tablet application for remote monitoring or respiratory health. They will be followed over time with surveys as well as chart review to assess effects of adding these mobile monitoring elements to their standard care.